why choose us

First received: February 17, 2023

Clinical Trial: A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Acute Myeloid Leukemia

Study Type: INTERVENTIONAL


Official Title: A Phase I Study of ADCLEC.syn1 CAR T Cells in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia

Brief Summary: The purpose of this study is to test the safety of ADCLEC.syn1CAR T cells in people with relapsed or refractory AML.The researchers will try to find the highest dose of ADCLEC.syn1CAR T cells that causes few or mild side effects in participants.Once the researchers find this dose, it will test it in a new group of participants to see if it is effective in treating their relapsed/refractory AML.

Read more